A non-profit member organization

Andes Biotechnologies

September 21, 2018

Andes Biotechnologies is a leading nucleic acid-based drug discovery and development company focused on solid tumor cancers.

Sign up for LAVCA’s bi-weekly Latin American Private Capital Update and the LatAm Venture Bulletin, produced specifically for venture investors, entrepreneurs, and technology startups in the early stage ecosystem.

Email Address *

First Name *

Last Name *

Company *

Country

Which LAVCA Newsletter would you like to receive?

Check out this week's top #startup deals and news on emerging tech in #LatAm from LAVCA's #LatAmVentureBulletin:… https://t.co/NOvUvkCflB

27-Jan-2023

Reply Retweet Favorite
#VC investment in #LatAm in 2022 reached USD7.5b, according to preliminary LAVCA data. Stay tuned for LAVCA’s yea… https://t.co/kAqAuL8Iq5

23-Jan-2023

Reply Retweet Favorite
January 20 is the last chance to register for "ESG in Venture and Tech Investing," the latest training in the LAVCA… https://t.co/UrbfcPgM7l

19-Jan-2023

Reply Retweet Favorite
Submissions for the 2023 LAVCA ESG Deal Awards are closing on January 20, 2023. LAVCA's ninth annual showcase will… https://t.co/AIu4FVKxT6

11-Jan-2023

Reply Retweet Favorite
Thank you for your continued support and commitment to grow private capital investment in Latin America. We look fo… https://t.co/AHA1txwyJZ

30-Dec-2022

Reply Retweet Favorite